Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 813 results for "bristol myers squibb"

Bristol-Myers Squibb Company (NYSE:BMY) Receives New Coverage by Hilliard Lyons with Neutral Rating

Webster Bank N. A. Acquires 1,700 Shares of Bristol-Myers Squi...

Webster Bank N. A. raised its stake in shares of Bristol-Myers Squibb Co (NYSE:BMY) by 4.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 43,928 shares of the ... Ticker Report, 5 hours ago

67 images for bristol myers squibb

Octafinance, 4 days ago, 1 week ago
Octafinance, 4 days ago
BioMedReports, 1 week ago
Pharma Letter, 1 week ago, 1 week ago, 1 week ago, 3 weeks ago
Business Insider Malaysia, 3 days ago
Nasdaq, 2 weeks ago

3 Stories To Watch At The Big Cancer Meeting

Bristol-Myers Squibb vs. Merck, Pfizervs. Lilly and a unique treatment from AbbVie ( ABBV ) will take the spotlight next week at the biggest drug conference focused on treatments for one of the biggest diseases: cancer. The annual meeting of the ...
 Investor's Business Daily5 hours ago 3 Stories To Watch At The Year's Biggest Cancer Conference  Marketplace6 hours ago Healthcare Sector Is Looking A Tad Better: M&A Boosts Biotech…Update  Fat Pitch Financials3 days ago Large Cap Best & Worst Report  Fat Pitch Financials3 days ago

Inside Bristol-Myers Squibb's Oncology Segment

What's Really Driving Bristol-Myers Squibb's Valuation? ( Continued from Prior Part ) The Oncology segment With strong performance of Opdivo, Bristol-Myers Squibb's (BMY) Oncology segment has emerged as the largest revenue contributor for the ...
 Yahoo! Finance UK and Ireland1 day ago Behind Bristol-Myers Squibb's Continued Growth in 1Q16  Yahoo! 7 Finance2 days ago Inside Bristol-Myers Squibb's Virology Segment  Yahoo! Finance1 day ago

Inovalon And Bristol-Myers Squibb Strike Deal To Focus On Real World Outcomes & Value-Based Contracting Initiatives

Inovalon (Nasdaq: INOV ) and Bristol-Myers Squibb (NYSE: BMY ) struck an agreement to bring Inovalon and Avalere's combined capabilities to bear on supporting real-world outcomes, as well as value-based contracting initiatives. According to the two ...
 Benzinga.com1 week ago

Bristol-Myers' Opdivo Wins FDA Nod for Additional Indication

Bristol-Myers Squibb Company BMY announced that the FDA has approved Opdivo for the treatment of classical Hodgkin lymphoma (cHL) in patients who have relapsed or progressed after autologous hematopoietic stem cell transplantation (auto-HSCT) and ...
 Yahoo! Finance1 week ago

US drugmaker Bristol Myers Squibb out of Biocon's oral insulin project

MUMBAI:Bengaluru-based Biocon will have to develop oral forms of insulin on its own as US drugmaker Bristol Myers Squibb , its global partner for the project, has "not exercised the option". Sector experts, however, said Biocon will continue to look ...
 Economic Times1 week ago Bristol-Myers Squibb pulls out of Biocon oral insulin pact  FierceBiotech1 week ago

How big investor is playing Bristol-Myers

A large investor extended a bullish position in Bristol-Myers Squibb just before yesterday's session ended. optionMONSTER's monitoring program shows that 23,973 June 75 calls were sold in one print for $0.17 and 13,837 July 72.50 calls were ...
 Option Monster1 day ago How large trader playing Bristol-Myers  Option Monster1 day ago

Is Bristol-Myers Squibb's Valuation High?

What's Really Driving Bristol-Myers Squibb's Valuation? Bristol-Myers's valuation On May 24, 2016, Bristol-Myers Squibb (BMY) was trading at a forward PE (price-to-earnings) multiple of ~24.7x, as compared to the industry average of 16.1x. Over ...
 Yahoo! 7 Finance2 days ago Baron Funds Comments on Bristol-Myers Squibb  Guru Focus4 days ago Experts Take A Step Toward a Birth Control Pill for Men  Med India2 months ago

Allied-Bristol Life Sciences completes ABLS II drug candidate feasibility programme

Allied-Bristol Life Sciences (ABLS), its partnership with Bristol-Myers Squibb Company (BMS), has completed the drug candidate feasibility programme at ABLS II, LLC (ABLS II), and approved up to $15m to fund further development of the lead ...
 Pharmaceutical Business Review2 days ago ABLS II completes drug feasibility programme  Stock Market Wire3 days ago ALLIED MINDS : Announces Successful Completion of ABLS II Drug Candidate Feasibility Program and Approval of Up to $15 Million to Fund Further Drug Development  4 Traders3 days ago Allied Minds announces successful completion of feasibility programme  Yahoo! Finance UK and Ireland3 days ago

Inovalon Announces Agreement with Bristol-Myers Squibb to Focus on Real World Outcomes & Value-Based Contracting Initiatives

Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based analytics and data-driven intervention platforms to the healthcare industry, today announced that it has entered into an agreement with Bristol-Myers Squibb ...
 Minyanville1 week ago BRIEF-Inovalon Holdings announces agreement with Bristol-Myers Squibb  Reuters UK1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
Get updated on latest news & your favorite topics right in your inbox!
More     Less